Having chosen a climate-change denier to head the US government's environment agency, an opponent of minimum wage for the Labor Department, a creationist for Education Secretary, a mine-owner for Commerce, and a wrestling exec to oversee small businesses – president-elect Donald Trump is now considering putting a man with very strange ideas about medicine as head of Uncle Sam's Food and Drug Administration.
It is probably no coincidence that Jim O'Neill is a close business associate of gay contrarian Peter Thiel, aka the Only Man in Silicon Valley to Support Trump. Having taken a wild punt on Trump to win, Thiel has now become one of the Donald's advisors.
O'Neill is managing director of one of Thiel's investment funds, Mithril Capital Management, having previously been MD of a different Thiel hedge fund, Clarium Capital. He also launched the Thiel Fellowship, which pays students to drop out of college to take a stab at becoming entrepreneurs. And like his billionaire pal, O'Neill has some peculiar beliefs.
For example, he is on the board of the
Seasteading Institute, which envisions setting up independent societies at sea, imbued with libertarian philosophies. That would ensure "freedom," according to O'Neill.
Far more relevant in relation to a possible FDA role, however, is the fact that O'Neill,
like Thiel, believes that it is possible to reverse the effects of aging by, um, taking the blood of young people and pumping it into old people like them. Scientists think it's
not that simple.